Table 3.
Plasmid conjugation studies.
| Disk diffusion test* | PCR | |||
|---|---|---|---|---|
| Strains | MIC to colistin (μg/mL) | NAL | CIP | mcr-1/PMQR/CTX-M |
| E. coli 190-14 | 8 | R | R | mcr-1+ qnrB+qnrS+CTX-M-2 |
| EC190-14 TC** | 4 | I | S | mcr-1+ qnrB |
| E. coli 191-07 | 8 | I | S | mcr-1+ qnrB+ CTX-M-2+ CMY-2 |
| EC191-07 TC** | 4 | I | S | mcr-1+ qnrB |
| E. coli J53 | 0,5 | S | S | – |
| EC191-07 TCS*** | 8 | I | S | mcr-1+ qnrB |
| Salmonella M1744 | 1 | S | – | – |
(R) resistant, (I) intermediate and (S) susceptible by disk diffusion test: Nalidixic Acid (NAL), Ciprofloxacin (CIP).
TC: transconjugants obtained using E. coli J53 as the recipient strain.
TCS: transconjugants obtained using Salmonella M1744 as the recipient strain.